TLS Online TPP Program

#Question id: 1430


2-hydroxyglutarate is produced in cancer cells:

#Unit 4. Cell Communication and Cell Signaling
  1. because cancer cells exhibit increased aerobic glycolysis.

  2. that have mutations in isocitrate dehydrogenase.

  3. to counteract all the lactate produced by aerobic glycolysis.

  4. that have mutations in alpha-ketoglutarate dehydrogense.

More Questions
TLS Online TPP Program

#Question id: 7257

#Unit 5. Developmental Biology

Following statements are regarding to the specification of anterior-posterior axis in drosophila.

A. The oocyte moves into the posterior region of the egg chamber, while nurse cells fill the anterior portion. The oocyte nucleus moves toward the terminal follicle cells and synthesizes Gurken protein.

B. When Gurken binds to Torpedo, the terminal follicle cells differentiate into posterior follicle cells and synthesize a molecule that activates protein kinase A in the egg.

C. Bicoid mRNA binds to dynein, a “plus-directed” motor protein associated with the nongrowing end of microtubules; dynein moves the bicoid mRNA to the anterior end of the egg.

D. Oskar mRNA becomes complexed to kinesin I, a “minus-directed” motor protein that moves it toward the growing end of the microtubules at the posterior region, where Oskar protein can bind nanos mRNA.

Which of the following is incorrect?

TLS Online TPP Program

#Question id: 607

#Unit 1. Molecules and their Interaction Relevant to Biology

In E. coli ________ is an activator and ________ is a negative allosteric modulator of the enzyme phosphofructokinase-1. 

TLS Online TPP Program

#Question id: 15006

#Unit 8. Inheritance Biology

Which of the following is not a mechanism for sex determination?

TLS Online TPP Program

#Question id: 26570

#Unit 3. Fundamental Processes

Which of the following is responsible for the deacetylation of histone

TLS Online TPP Program

#Question id: 31041

#Unit 4. Cell Communication and Cell Signaling

Which of the following statement is incorrect regarding HER2?